- By insider
President & CEO of Turning Point Therapeutics Inc (TPTX) Athena Countouriotis bought 12,000 shares of TPTX on 04/22/2019 at an average price of $18 a share. The total cost of this purchase was $216,000.
Turning Point Therapeutics Inc has a market cap of $837.430 million; its shares were traded at around $28.24 .
-
Warning! GuruFocus has detected 1 Warning Sign with GH. Click here to check it out.
-
The intrinsic value of TPTX
CEO Recent Trades:
-
President & CEO Athena Countouriotis bought 12,000 shares of TPTX stock on 04/22/2019 at the average price of $18. The price of the stock has increased by 56.89% since.
Directors and Officers Recent Trades:
-
VP of Finance and Admin. Brian Lee Baker bought 2,800 shares of TPTX stock on 04/22/2019 at the average price of $18. The price of the stock has increased by 56.89% since.
-
Director Advisors Llc Orbimed bought 360,000 shares of TPTX stock on 04/22/2019 at the average price of $18. The price of the stock has increased by 56.89% since.
-
Director Hongbo Lu bought 60,000 shares of TPTX stock on 04/22/2019 at the average price of $18. The price of the stock has increased by 56.89% since.
-
Director Carl L Gordon bought 360,000 shares of TPTX stock on 04/22/2019 at the average price of $18. The price of the stock has increased by 56.89% since.
-
Director Simeon George bought 325,000 shares of TPTX stock on 04/22/2019 at the average price of $18. The price of the stock has increased by 56.89% since.
For the complete insider trading history of TPTX, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 1 Warning Sign with GH. Click here to check it out.
-
The intrinsic value of TPTX